drugset / Trial / NCT03884296

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood

NCT03884296

NaSingle-groupOpen-labelBasic science

Summary

This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to investigate the immune response to a nasal flu immunization in tonsillar tissue compared to what can be measured in the blood.

Timeline

Start
2019-04-15
Primary completion
2023-11-17
Completion
2023-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject FluMist Vaccine Intranasal

Indications